In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
How Can We Afford to? How can we afford not to?
The issue arises from differing perspectives on facts and opinions regarding a situation and its consequences. Ultimately, it’s…
Gleason Corporation Acquires Intra Group of Companies
Gleason Corporation announced it has acquired 100% of the shares of the Intra Group of Companies with its…
Octave Launches New Brand Built Around Unleashing Intelligence at Scale
Drawing on decades of expertise, the potential Hexagon spin-off helps organizations navigate uncertainty and manage change across the…
